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Background: Transplantation of kidneys from deceased donors 
with acute renal failure (ARF) has been described and 
represents an underutilized source of renal grafts. We 
reviewed retrospectively our double center experience with 
transplantation of ARF donor kidneys.  
 
Methods: Between January 2009 and June 2014, we 
performed a total of 397 kidney transplants at the two 
hospitals.  Of which, 65 came from donors with ARF. The 
outcome was compared with 62 expanded criteria donor 
kidneys and 270 standard criteria donor kidneys. ARF was 
defined as donor terminal creatinine higher than 2. All kidneys 
from ARF donors had acceptable biopsies and were pumped. 
The immunosuppression was similar in all three groups 
(Thymoglobulin for induction and Prograf, Cellcept and 
steroids for maintenance). The outcome measurements 
included recipient serum creatinine, patient and graft survival 
at 6 months, 1 year and 3 years. We also reviewed the 
delayed graft function (DGF) rates and cold ischemic time in all 
groups. 
 
Results: Mean donor creatinine was 3.84±1.3. The 6 month, 1 
and 3 year patient survival rates were 98.5%, 96.8% and 
92.0% in ARF group, 98.1%, 97.0% and 93.4% SCD group 
and 98.4%, 93.2% and 77.7% in ECD group. The 6 month, 1 
and 3 year death censored graft survival was 96.9%, 96.9%, 
96.9% in ARF group, 97.7, 96.5, 91.8 in SCD group and 
95.1%, 93.2%, 90.1% in ECD group. The mean 6mo, 1 year 
and 3 year recipient creatinine was 1.49, 1.46 and 1.51 in ARF 
group, 1.61, 1.72 and 1.77 in SCD group and 1.91, 1.92 and 
2.15 in ECD group, respectively. ARF kidneys are noted to be 
associated with more DGF (58.5% in ARF group VS 41.5% in 
non ARF group), longer cold ischemic time (857.79 min in ARF 
group vs 589.32 min in non ARF group) and younger donor 
age (32.25 years in ARF group vs 40.65 years in non ARF 
group). 
 
Conclusion: Elevated terminal donor creatinine is not a risk 
factor for graft loss after deceased donor kidney 
transplantation. Although there is increased risk of DGF and 
longer cold ischemic time, transplantation of ARF kidneys 
provides comparable short and long term graft function and 
patient survival compared to kidneys from non ARF donors.  
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Results: Recipient Outcomes 
Background 
•  Transplantation of kidneys from deceased 
donors with acute renal failure (ARF) has been 
described and represents an underutilized 
source of renal grafts 
•  We retrospectively reviewed our double center 
experience with transplantation of ARF donor 
kidneys 
 
Conclusions 
 
•  Elevated terminal donor Creatinine is not a risk factor for graft loss after deceased donor kidney 
transplantation 
•  Although there is increased risk of DGF and longer CIT, transplantation of ARF kidneys provides 
comparable short and long term graft function and patient survival compared to kidneys from non-
ARF donors 
  
         ARF    Non ARF    P-value 
Donor Age (years)      32.3      40.7        <0.005 
Terminal Donor Cr (mean)          4.20      0.97     <0.005 
CIT (min)        857.8      589.3       <0.005 
DGF (%)             58.5         41.5         <0.005 
Results: Donor and Recipient Characteristics 
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Patient Survival (%) ARF SCD ECD 
     6 months 98.5 98.1 98.4 
      1 year 96.8 97.0 93.2 
      3 years 92.0 93.4 77.7 
Graft Survival (%)    
      6 months 96.9 97.7 95.1 
      1 year 96.9 96.5 93.2 
      3 years 96.9 91.8 90.1 
Recipient Creatinine  (Mg/dl)    
      6 months 1.49 1.61 1.91 
      1 year 1.46 1.72 1.92 
      3 years 1.51 1.77 2.15 
Methods 
•  397 kidney transplants were performed from 
January 2009- June 2014 at TJUH and LMC 
•  65 kidney grafts came from donors with ARF  
•  Outcome was compared with 62 expanded 
criteria donor (ECD) kidneys and 270 standard 
criteria donor (SCD) kidneys 
•  ARF was defined as donor terminal Creatinine 
> 2 mg/dl  
•  All kidney grafts from ARF donors had 
acceptable biopsies and were placed on 
machine perfusion pump 
•  Immunosuppression was similar in all three 
groups:  
     Induction: Thymoglobulin, steroid  
     Maintenance: Tacrolimus, MMF, steroids 
•  Outcome measurements included: 
•  Recipient serum Creatinine 
•  Delayed graft function (DGF) rates 
•  Patient and graft survival rates at 6 months, 1 
year and 3 years 
•  Cold ischemic times (CIT) 
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